Article
Clinical Prediction Models for Treatment Outcomes in Newly-diagnosed Epilepsy
2024-01-13
Abstract excerpt
<h4>Background</h4> Up to 35% of individuals diagnosed with epilepsy proceed to develop pharmacoresistant epilepsy, leading to persistent uncontrolled seizure activity that can directly, or indirectly, significantly degrade an individual’s quality of life. The factors underlying pharmacoresistance are unclear, but it has been hypothesised that repeated ictogenic activity is conducive to the development of a more r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 95d32291-2fc1-5a9c-ae26-b1ce460d35ec
- DOI
- 10.1101/2024.01.12.24301215
